• QX77: Advancing Chaperone-Mediated Autophagy for Precision R

  2026-06-22

  Explore how QX77, a molecular chaperone activator, uniquely empowers chaperone-mediated autophagy and stem cell biology research. This article delivers a deeper mechanistic analysis, integrating the latest scientific evidence and practical assay guidance.

• Biotin (Vitamin B7) in Protein Biotinylation & Metabolic Res

  2026-06-21

  Biotin (Vitamin B7) stands out as an essential coenzyme and powerful labeling reagent, streamlining workflows from metabolic pathway studies to advanced protein biotinylation. Explore how APExBIO’s high-purity biotin enables robust, reproducible results, with protocol tips and troubleshooting grounded in the latest kinesin transport research.

• Paclitaxel (Taxol) in Cancer Research: Protocols and Optimiz

  2026-06-20

  Paclitaxel (Taxol) is an indispensable tool for dissecting microtubule dynamics and cell cycle arrest across cancer models. This article delivers up-to-date, evidence-backed workflows, troubleshooting strategies, and contextual insight—empowering translational researchers to maximize the impact of Paclitaxel in preclinical and mechanistic studies.

• CLK2 Drives Platinum Resistance in Ovarian Cancer via BRCA1

  2026-06-19

  This study reveals that Cdc2-like kinase 2 (CLK2) underlies platinum resistance in ovarian cancer by enhancing BRCA1-mediated DNA repair. The findings provide a mechanistic rationale for targeting DNA damage response pathways in efforts to overcome chemotherapy resistance.

• Enhanced A40926 Production via Engineered Nonomuraea Strains

  2026-06-19

  This study demonstrates a combined strategy of genetic engineering and medium optimization to significantly increase the fermentation yield of A40926, the glycopeptide dalbavancin precursor. The findings provide a robust framework for scalable antibiotic production, supporting advanced research into cell wall synthesis inhibitors and multidrug-resistant pathogens.

• Belinostat (PXD101): Applied Workflows in Epigenetic Cancer

  2026-06-18

  Belinostat (PXD101), a potent pan-HDAC inhibitor from APExBIO, enables precise modulation of gene expression and robust inhibition of cancer cell proliferation. This article delivers stepwise workflows, advanced troubleshooting, and actionable insights to optimize your epigenetic cancer research, with data-driven guidance for both in vitro and in vivo studies.

• Carvacrol (5-isopropyl-2-methylphenol): Mechanisms & Redox R

  2026-06-18

  Carvacrol, also known as 5-isopropyl-2-methylphenol, is a monoterpene phenol with established antibacterial, antioxidant, and anticancer activities. Mechanistic studies demonstrate its ability to induce cell cycle arrest and modulate ion channel redox responses. This dossier provides precise, evidence-linked parameters for research use.

• A-769662: AMPK Activator Workflows for Metabolic Research

  2026-06-17

  A-769662 delivers precise, reversible AMPK activation, offering robust control over energy metabolism and autophagy suppression in cellular models. This article details advanced experimental workflows, practical troubleshooting, and evidence-driven optimizations to harness A-769662 for metabolic and type 2 diabetes research.

• Fluconazole as a Strategic Driver in Next-Gen Antifungal Res

  2026-06-17

  This thought-leadership article guides translational researchers in leveraging Fluconazole as a precision tool for dissecting fungal pathogenesis, resistance evolution, and mucosal defense. It integrates mechanistic insights from host-fungal cross-talk, highlights APExBIO’s rigorous product intelligence, and discusses protocol, competitive, and translational strategy—offering a unique perspective beyond standard product summaries.

• Morin: Protocol Optimization & Applied Innovations in Diseas

  2026-06-16

  Morin, a high-purity natural flavonoid from APExBIO, stands apart for its dual role as a bioactive modulator and fluorescent probe in complex disease research. Explore actionable workflows, troubleshooting insights, and advanced use-cases that maximize Morin’s unique properties for translational impact.

• Auranofin: Redox Disruption and Cytoskeletal Crosstalk in On

  2026-06-16

  This thought-leadership article explores how Auranofin, a potent thioredoxin reductase inhibitor, is redefining translational research by integrating redox biology, apoptosis, radiosensitization, and cytoskeleton-dependent autophagy. Building on recent mechanistic studies and clinical benchmarks, we offer strategic guidance for experimental design and highlight APExBIO’s leadership in advancing next-generation oncology and infectious disease models.

• Rocilinostat (ACY-1215): Selective HDAC6 Inhibitor for Myelo

  2026-06-15

  Rocilinostat (ACY-1215) is a potent, selective HDAC6 inhibitor that disrupts cancer cell survival and metastasis. Preclinical models show significant efficacy in multiple myeloma, especially in combination therapies. The compound is DMSO-soluble and requires cold-chain handling.

• Dissecting A40926 Biosynthesis: Insights into Dalbavancin Pr

  2026-06-15

  This review analyzes the 2006 reference paper's advances in understanding and engineering the biosynthetic pathway of A40926, a key glycopeptide antibiotic and direct precursor to dalbavancin. The paper's dissection of gene clusters and pathway manipulation enabled rational creation of novel derivatives, shaping antibiotic development strategies for Gram-positive pathogens.

• Advances in Removing Pollen Interference in Bioaerosol Detec

  2026-06-14

  This study introduces a robust approach for eliminating pollen spectral interference in the classification of hazardous substances using excitation–emission matrix fluorescence spectroscopy. The integration of advanced preprocessing and machine learning significantly enhances the accuracy of bioaerosol monitoring, offering practical implications for public health and rapid detection of toxins or pathogens.

• Biosynthetic Pathway Engineering of A40926: Insights and Adv

  2026-06-13

  This review uncovers the genetic and biosynthetic innovations underlying A40926, the natural precursor of dalbavancin. By elucidating the dbv gene cluster and its manipulation, the reference paper sets the stage for advanced glycopeptide antibiotic development and new strategies to combat resistant Gram-positive pathogens.

454 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page